Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/89024
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Gray, T.L. | - |
| dc.contributor.author | Wong, H.C. | - |
| dc.contributor.author | Raymond, G.L. | - |
| dc.date.issued | 2012 | - |
| dc.identifier.citation | Retinal Cases and Brief Reports, 2012; 6(2):193-196 | - |
| dc.identifier.issn | 1935-1089 | - |
| dc.identifier.issn | 1937-1578 | - |
| dc.identifier.uri | http://hdl.handle.net/2440/89024 | - |
| dc.description.abstract | Abstract not available | - |
| dc.description.statementofresponsibility | Tim L. Gray, Hong-Chai Wong, Grant L. Raymond | - |
| dc.language.iso | en | - |
| dc.publisher | Ophthalmic Communications Society | - |
| dc.rights | © 2012 Ophthalmic Communications Society, Inc. | - |
| dc.source.uri | http://dx.doi.org/10.1097/icb.0b013e31822476fd | - |
| dc.subject | bevacizumab; choroidal neovascularization; Sorsby fundus dystrophy | - |
| dc.title | Choroidal neovascularization secondary to sorsby fundus dystrophy treated with intravitreal bevacizumab | - |
| dc.type | Journal article | - |
| dc.identifier.doi | 10.1097/ICB.0b013e31822476fd | - |
| pubs.publication-status | Published | - |
| Appears in Collections: | Aurora harvest 2 Opthalmology & Visual Sciences publications | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.